Management of Myxofibrosarcoma and Undifferentiated Pleomorphic Sarcoma.
Crago AM, Cardona K, Koseła-Paterczyk H, Rutkowski P.
Surg Oncol Clin N Am. 2022 Jul;31(3):419-430. doi: 10.1016/j.soc.2022.03.006.
Undifferentiated Pleomorphic Sarcoma.
Menon G, Solis-Ledesma G.
2025 Jun 23. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
Comparison of Features and Outcomes of Undifferentiated Pleomorphic Sarcoma of Bone and Soft Tissue.
Gusho CA, Lee L, Guntin J, Blank AT.
J Surg Res. 2022 Feb;270:313-320. doi: 10.1016/j.jss.2021.09.032. Epub 2021 Oct 29.
Predicting the prognosis of undifferentiated pleomorphic soft tissue sarcoma: a 20-year experience of 266 cases.
Vodanovich DA, Spelman T, May D, Slavin J, Choong PFM.
ANZ J Surg. 2019 Sep;89(9):1045-1050. doi: 10.1111/ans.15348. Epub 2019 Jul 30.
Review of primary superficial soft tissue mesenchymal tumors of malignant or intermediate biological potential.
Oettel DJ, Bernard SA.
Skeletal Radiol. 2023 Mar;52(3):435-445. doi: 10.1007/s00256-022-04127-0. Epub 2022 Jul 22.
UNDIFFERENTIATED PLEOMORPHIC SARCOMA: PROGNOSTIC FACTORS IN 42 EXTREMITY CASES.
Maçaneiro CH, Baptista AM, Camargo OP, Filippi RZ, Oliveira ET.
Acta Ortop Bras. 2023 May 1;31(2):e265942. doi: 10.1590/1413-785220233102e265942. eCollection 2023.
Soft-Tissue Sarcomas of the Abdomen and Pelvis: Radiologic-Pathologic Features, Part 2-Uncommon Sarcomas.
Levy AD, Manning MA, Miettinen MM.
Radiographics. 2017 May-Jun;37(3):797-812. doi: 10.1148/rg.2017160201.
A League of Its Own? Established and Emerging Therapies in Undifferentiated Pleomorphic Sarcoma.
Graves L, Jeck WR, Grilley-Olson JE.
Curr Treat Options Oncol. 2023 Mar;24(3):212-228. doi: 10.1007/s11864-023-01054-7. Epub 2023 Feb 2.
Reconstruction of upper limb soft-tissue defects after sarcoma resection with free flaps: A systematic review.
Lucattelli E, Lusetti IL, Cipriani F, Innocenti A, De Santis G, Innocenti M.
J Plast Reconstr Aesthet Surg. 2021 Apr;74(4):755-767. doi: 10.1016/j.bjps.2020.10.065. Epub 2020 Nov 8.
Single-cell and spatial transcriptomics identify COL6A3 as a prognostic biomarker in undifferentiated pleomorphic sarcoma.
Klein JC, Wang L, Strand D, Lastufka C, Hosler GA, Hon GC.
Mol Cancer. 2024 Nov 15;23(1):257. doi: 10.1186/s12943-024-02168-8.
